Business Responsibility and Sustainability Report for the financial year ended March 31, 2026

An ISO 9001 & ISO 13485 Certified Company Date: September 02, 2026 To, To, BSE Limited (“BSE”), National Stock Exchange of India Limited (“NSE”) Corporate Relationship Department, “Exchange Plaza”, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, P.J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (East), Mumbai – 400001 Mumbai – 400051 BSE Scrip code: 543399 NSE Symbol: TARSONS Subject: Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2026 Dear Sir/Madam, Pursuant to the provisions of Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“Listing Regulations”), we are submitting herewith the Business Responsibility and Sustainability Report (‘BRSR’) of the Company for the Financial Year 2025-26, which also forms part of the Annual Report for the Financial Year 2025-26. The said information is also being made available on the Company’s website at www.tarsons.com. You are kindly requested to take the same on your record. Thanking you Yours Faithfully, For Tarsons Products Limited Santosh Kumar Agarwal CFO, Company Secretary & Compliance Officer ICSI Membership No. A44836 Encl: As above Tarsons Products Limited, 902, Martin Burn Business Park, BP-3, Sector –V, Salt Lake, Kolkata – 700091 Tel: +91 33 3522 0300, Web: www.tarsons.com Mail: info@tarsons.com, CIN: L51109WB1983PLC036510 ANNEXURE VI BUSINESS RESPONSIBILITY & SUSTAINABILITY REPORT (Business Responsibility and Sustainability Reporting (BRSR) is the practice of companies disclosing information about their environmental, social, and governance (ESG) performance. It goes beyond financial reporting to provide stakeholders with a comprehensive view of a company’s non-financial impacts and contributions to sustainable development. BRSR covers topics such as environmental impact, social responsibility, and governance practices, aiming to promote transparency and accountability.) SECTION A: GENERAL DISCLOSURES I. Details of the listed entity Sr. Particulars 2025-26 1 Corporate Identity Number (CIN) of the Listed Entity L51109WB1983PLC036510 2 Name of the Listed Entity TARSONS PRODUCTS LIMITED 3 Year of incorporation 5th July, 1983 4 Registered office address Martin Burn Business Park, Room No. 902 BP- 3, Salt Lake, Sector - V, Kolkata, West Bengal - 700091 5 Corporate address Martin Burn Business Park, Room No. 902 BP- 3, Salt Lake, Sector - V, Kolkata, West Bengal - 700091 6 E-mail info@tarsons.com & investor@tarsons.com 7 Telephone 033-35220300 8 Website www.tarsons.com 9 Financial year for which reporting is being done 1st April, 2025 to 31st March, 2026 10 Name of the Stock Exchange(s) where shares are listed Bombay Stock Exchange (BSE) & National Stock Exchange (NSE) 11 Paid-up Capital ` 10,64,12,562 divided into 5,32,06,281 equity shares of Rupees 2 each 12 Name and contact details (telephone, email address) of Santosh Kumar Agarwal the person who may be contacted in case of any queries CFO & Company Secretary on the BRSR report 033 3522-0300 investor@tarsons.com 13 Reporting boundary - Are the disclosures under this Standalone report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together) 14 Name of assurance provider Not Applicable 15 Type of assurance obtained Not Applicable II. Products/services 16. Details of business activities (accounting for 90% of the turnover): Sr. Description of Main Description of Business Activity % of Turnover of No. Activity the entity 1. Manufacturing Manufacture of rubber and plastics products 94% 2. Wholesale and retail trade; Wholesale trade, except of motor vehicles and motorcycles 6% repair of motor vehicles and motorcycles BRSR 2025-26 ANNEXURE VI (Contd.) 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): Sr. Product/Service NIC Code % of total Turnover No. Contributed 1. Manufacture of plastics Labware products 22209 100% III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 7 5 12 International 0 0 0 19. Markets served by the entity: a. Number of locations Locations Number* National (No. of States) 28 International (No. of Countries) 40+ *Note: National: The Company operates across various states in India through its offices, dealers, and website. International: The Company has a presence in multiple countries through exports, subsidiaries, joint ventures, sales offices, or direct operations. b. What is the contribution of exports as a 31% percentage of the total turnover of the entity? c. A brief on types of customers Tarsons derives a significant share of its revenue from two primary customer segments, Contract Research Organizations (CROs) and the pharmaceutical sector. The remaining revenue is generated from a diverse range of sectors, including diagnostics, academia, colleges, universities, in vitro fertilization (IVF) centers, and hospitals. IV. Employees 20. Details as at the end of Financial Year: a. Employees and workers (including differently abled): Sr. Particulars Total (A) Male Female No. (B) % (B/A) No. (C) % (C/A) EMPLOYEES 1 Permanent (D) 165 149 90.30% 16 9.70% 2 Other than Permanent (E) 0 0 0% 0 0% 3 Total employees (D + E) 165 149 90.30% 16 9.70% WORKERS 4 Permanent (F) 943 942 99.89% 1 00.11% 5 Other than Permanent (G) 0 0 0% 0 0% 6 Total workers (F + G) 943 942 99.89% 1 00.11% Tarsons Products Limited ANNEXURE VI (Contd.) b. Differently abled Employees and workers: Sr. Particulars Total Male Female No. (A) No. (B) % (B/A) No. (C) % (C/A) DIFFERENTLY ABLED EMPLOYEES 1 Permanent (D) 0 0 0% 0 0% 2 Other than Permanent (E) 0 0 0% 0 0% 3 Total differently abled employees (D + E) 0 0 0% 0 0% DIFFERENTLY ABLED WORKERS 4 Permanent (F) 0 0 0% 0 0% 5 Other than Permanent (E) 0 0 0% 0 0% 6 Total differently abled workers (F + G) 0 0 0% 0 0% 21. Participation/Inclusion/Representation of women Particular Total (A) No. and percentage of Females No. (B) % (B/A) Board of Directors 8 2 25% Key Management Personnel 1 0 0% Note: The roles of KMP and BoD are clearly defined and do not overlap. 22. Turnover rate for permanent employees and workers Particular 2025-26 2024-25 2023-24 (Turnover rate in (Turnover rate in (Turnover rate in the year current FY) previous FY) prior to the previous FY) Male Female Total Male Female Total Male Female Total Permanent Employees 24.83% 31.25% 25.45% 9.82% 26.67% 11.43% 9.34% 21.43% 7.72% Permanent Workers 21.50% 0% 21.47% 9.06% 0% 9.05% 9.42% 0% 9.42% V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) Names of holding/subsidiary/associate companies/joint ventures Sr. Name of the holding/ Indicate whether % of shares held Does the entity indicated No. subsidiary/associate holding/subsidiary/ by listed entity at column A, participate in companies/joint Associate/Joint the Business responsibility ventures (A) Venture initiatives of the listed entity? (Yes/No) 1. Tarsons Life Science Pte Subsidiary 100% No Note: We also have two wholly owned step-down subsidiaries: Nerbe R&D GmbH and Nerbe Plus GmbH & Co. KG. VI. CSR Details 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No) Yes a. Turnover (in `) 3,14,17,73,160.64 b. Net worth (in `) 6,51,79,50,727.87 Note: Since this report pertains to 2025–26, the above turnover and net worth figures pertain to the immediately preceding financial year ended 31st March, 2025, as required for determining the applicability of CSR under Section 135 of the Companies Act, 2013. BRSR 2025-26 ANNEXURE VI (Contd.) VII. Transparency and Disclosures Compliances 25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible Business Conduct: [Showing first 8,000 characters — download PDF for full document]